Pharmacokinetics and immunogenicity of broadly neutralizing HIV monoclonal antibodies in macaques.
The identification of highly potent broadly neutralizing antibodies (bnAbs) against HIV-1, and success in preventing SHIV infection following their passive administration, have increased the likelihood that immunotherapeutic strategies can be adopted to prevent and treat HIV-1 infection. However, wh...
Main Authors: | Yvonne Rosenberg, Markus Sack, David Montefiori, Celia Labranche, Mark Lewis, Lori Urban, Lingjun Mao, Rainer Fischer, Xiaoming Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0120451 |
Similar Items
-
Rapid high-level production of functional HIV broadly neutralizing monoclonal antibodies in transient plant expression systems.
by: Yvonne Rosenberg, et al.
Published: (2013-01-01) -
Protection against SHIV Challenge by Subcutaneous Administration of the Plant-Derived PGT121 Broadly Neutralizing Antibody in Macaques.
by: Yvonne J Rosenberg, et al.
Published: (2016-01-01) -
Introduction of the YTE mutation into the non-immunogenic HIV bnAb PGT121 induces anti-drug antibodies in macaques.
by: Yvonne J Rosenberg, et al.
Published: (2019-01-01) -
A broadly neutralizing macaque monoclonal antibody against the HIV-1 V3-Glycan patch
by: Zijun Wang, et al.
Published: (2020-10-01) -
A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques
by: Sujin Lee, et al.
Published: (2016-09-01)